Active, Not Recruiting
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
NCT05919537
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
- Locations
-
- GenesisCare North Shore Sydney, New South Wales, Australia
- ICON Cancer Centre South Brisbane Brisbane, Queensland, Australia
- Southern Oncology Clinical Research Unit Adelaide, South Australia, Australia
- Cabrini Health Malvern, Victoria, Australia